Clinical Trial Update: Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device [NA]

View source ↗

Summary

A completed validation trial evaluated removal of EpCAM-positive tumor cells from blood collected during tumor surgery using the Catumaxomab/Catuvab device acro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Colon Cancer
• Endometrial Cancer
• Gallbladder Cancer
• Gastric Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• Catumaxomab (Catumaxomab)

Snippet

Sponsor: Lindis Bloodcare GmbH | Conditions: Bladder Carcinoma, Prostate Tumor | NA | Status: COMPLETED